Wa Xian and Frank McKeon found that three variant cells in all COPD patients drive all the key features of the disease
Single Cell Cloning Tells the Story of Abnormal Cells
Two internationally renowned stem cell experts at the University of Houston have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), a leading cause of death worldwide. Frank McKeon, professor of biology and biochemistry and director of the Stem Cell Center, and Wa Xian, research associate professor at the center, used single cell cloning of lung stem cells to make their discovery. Now they are targeting the cells for new therapeutics.
“We actually found that three variant cells in all COPD patients drive all the key features of the disease. One produces tremendous amounts of mucins which block the small airways, while the other two drive fibrosis and inflammation which together degrade the function of the lung,” Xian reports in the May 14 issue of the journal Cell. “These patients have normal stem cells, though not many of them, but they are dominated by the three variant cells that together make up the disease,” she said.
COPD is a progressive inflammatory disease of the lungs marked by chronic bronchitis, small airway occlusion, inflammation, fibrosis and destruction of alveoli, tiny air sacs in the lungs which exchange oxygen and carbon dioxide molecules in the blood. The Global Burden of Disease Study reports 251 million cases of COPD globally in 2016.
“It’s a frustrating disease to care for. We can try and improve the symptoms, but we don’t have anything that can cure the disease or prevent death,” said UConn Health pulmonologist and critical care doctor Mark Metersky, who gathered the stem cells from lung fluid while performing bronchoscopies.
Despite its accounting for more deaths than any single disease on the planet, relatively little has been written or understood about the root cause of COPD.
Over the past decade, Xian and McKeon developed technology for cloning stem cells of the lungs and airways and have been at it since, noting that different parts of the airways give different stem cells, related but distinguishable.
“It’s quite remarkable,” said McKeon. “In the deep lung, the distal airway stem cells gave rise to both the distal tubes and the alveoli and our research indicates those are the stem cells that make it possible for lungs to regenerate on their own.” Xian and McKeon discovered lung regeneration in 2011 in their studies of subjects recovering from infections by an H1N1 influenza virus that was nearly identical to that which sparked the 1918 pandemic.
Xian and McKeon found that, in contrast to normal lungs, COPD lungs were inundated by three unusual variant lung stem cells that are committed to form metaplastic lesions known to inhabit COPD lungs, but seen by many as a secondary effect without a causal link to the pathology of COPD. After the team’s postdoctoral fellow, Wei Rao, transplanted each of the COPD clones into immunodeficient subjects, the team found they not only gave rise to the distinct metaplastic lesions of COPD, but they separately triggered the triad of pathologies of COPD including mucus hypersecretion, fibrosis and chronic inflammation.
“The long-overlooked metaplastic lesions in COPD were, in fact, driving the disease rather than merely secondary consequences of the condition,” said McKeon.
Now that the team knows the identity of the cells that cause inflammation, fibrosis and small airway obstruction, they are hard at work screening them against libraries of drug-like molecules to discover new therapeutics.
“As we now know the specific cells responsible for COPD pathology, we can target them, much as we would cancer, with specific drugs that selectively kill them off and leave the normal cells to regenerate normal lung tissue,” said Xian.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COPD
- Harvard Health Publishing And 3 More Doctors Weigh In On: What Is The Life Expectancy And Outlook For Copd?
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA Life expectancy of chronic obstructive pulmonary disease is extremely variable, ...
- What Harvard Health Publishing And 3 Other Doctors Think: What Is The Life Expectancy And Outlook For Copd?
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA Life expectancy of chronic obstructive pulmonary disease is extremely variable, ...
- Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch
Anticipating approval for its COPD therapy ensifentrine, Verona has entered into a $650 million financing deal with Oaktree Capital Management and OMERS Life Sciences.
- Verona inks financing deal worth up to $650M ahead of COPD decision
Verona Pharma has secured up to $650 million to aid the potential launch of its COPD candidate ensifentrine. Under new agreements with Oaktree Capital Management and OMERS Life Sciences, Verona can ...
- The Best Exercises to Try If You Have COPD
While there’s no cure for chronic obstructive pulmonary disease (COPD), exercise can improve COPD symptoms and help you feel better. Breathing difficulties can make people with COPD feel like ...
Go deeper with Google Headlines on:
COPD
[google_news title=”” keyword=”COPD” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Lung stem cell disease
- Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infections
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight risks
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A doctor weighed in on the potential risks.
- Stem cell treatment for brain diseases praised
British scientists today welcomed research by their US counterparts into developing stem cell treatments for devastating brain diseases such ... gut and lung. Verfaillie's team has also discovered ...
- Drug Prototype Shows Promise for Stem Cell Treatment of Pulmonary Disease
In many pulmonary diseases, insufficient stem cells allow damage to progress, but researchers have developed a lung-targeted, drug-like small molecule to stimulate the growth of lung stem cells ...
- Drug Prototype May Enhance Lung Regeneration
For many progressive lung diseases like idiopathic pulmonary fibrosis (IPF), a key issue is a low supply of new stem cells to repair and reverse damage. These cells are responsible for regenerating ...
Go deeper with Google Headlines on:
Lung stem cell disease
[google_news title=”” keyword=”lung stem cell disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]